NCT06588348 - Corticosteroid Effect on Achalasia Variant EGJOO | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 26, 2022

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions

Esophagogastric Junction Outflow Obstruction

Interventions

DRUG

Steroid treatment

All enrolled subjects will be prescribed a 14-day course of corticosteroid therapy in the form of Prednisone 20 mg to be taken once daily by mouth.

PROCEDURE

Esophageal Manometry

On the final day of Prednisone use, all subjects will undergo esophageal manometry testing to assess for treatment response.

OTHER

Survey

All enrolled subjects will be asked to complete follow-up Eckardt and BEDQ surveys.

Trial Locations (1)

Baylor University Medical Center, Dallas